184 related articles for article (PubMed ID: 11862351)
1. The impact of tricyclic antidepressants and selective serotonin re-uptake inhibitors on handwriting movements of patients with depression.
Tucha O; Aschenbrenner S; Eichhammer P; Putzhammer A; Sartor H; Klein HE; Lange KW
Psychopharmacology (Berl); 2002 Jan; 159(2):211-5. PubMed ID: 11862351
[TBL] [Abstract][Full Text] [Related]
2. Differential effects of reboxetine and citalopram on hand-motor function in patients suffering from major depression.
Hegerl U; Mergl R; Henkel V; Pogarell O; Müller-Siecheneder F; Frodl T; Juckel G
Psychopharmacology (Berl); 2005 Feb; 178(1):58-66. PubMed ID: 15316714
[TBL] [Abstract][Full Text] [Related]
3. Effects of nicotine chewing gum on a real-life motor task: a kinematic analysis of handwriting movements in smokers and non-smokers.
Tucha O; Lange KW
Psychopharmacology (Berl); 2004 Apr; 173(1-2):49-56. PubMed ID: 14668975
[TBL] [Abstract][Full Text] [Related]
4. Kinematic analysis of dopaminergic effects on skilled handwriting movements in Parkinson's disease.
Tucha O; Mecklinger L; Thome J; Reiter A; Alders GL; Sartor H; Naumann M; Lange KW
J Neural Transm (Vienna); 2006 May; 113(5):609-23. PubMed ID: 16082511
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and tolerability of moclobemide in comparison with placebo, tricyclic antidepressants, and selective serotonin reuptake inhibitors in elderly depressed patients: a clinical overview.
Amrein R; Stabl M; Henauer S; Affolter E; Jonkanski I
Can J Psychiatry; 1997 Dec; 42(10):1043-50. PubMed ID: 9469236
[TBL] [Abstract][Full Text] [Related]
6. Selective serotonin reuptake inhibiting antidepressants are associated with an increased risk of nonvertebral fractures.
Ziere G; Dieleman JP; van der Cammen TJ; Hofman A; Pols HA; Stricker BH
J Clin Psychopharmacol; 2008 Aug; 28(4):411-7. PubMed ID: 18626268
[TBL] [Abstract][Full Text] [Related]
7. Hand-motor dysfunction in depression: characteristics and pharmacological effects.
Mergl R; Pogarell O; Juckel G; Rihl J; Henkel V; Frodl T; Müller-Siecheneder F; Karner M; Tigges P; Schröter A; Hegerl U
Clin EEG Neurosci; 2007 Apr; 38(2):82-8. PubMed ID: 17515173
[TBL] [Abstract][Full Text] [Related]
8. A comparison of side effects of selective serotonin reuptake inhibitors and tricyclic antidepressants in older depressed patients: a meta-analysis.
Wilson K; Mottram P
Int J Geriatr Psychiatry; 2004 Aug; 19(8):754-62. PubMed ID: 15290699
[TBL] [Abstract][Full Text] [Related]
9. SSRIS versus tricyclic antidepressants in depressed inpatients: a meta-analysis of efficacy and tolerability.
Anderson IM
Depress Anxiety; 1998; 7 Suppl 1():11-7. PubMed ID: 9597346
[TBL] [Abstract][Full Text] [Related]
10. Effects of selective serotonin reuptake inhibitors versus tricyclic antidepressants on cerebrovascular events: a nationwide population-based cohort study.
Lee YC; Lin CH; Lin MS; Lin JW; Chang CH; Lai MS
J Clin Psychopharmacol; 2013 Dec; 33(6):782-9. PubMed ID: 24091857
[TBL] [Abstract][Full Text] [Related]
11. Pharmacotherapy for major depression with melancholic features: relative efficacy of tricyclic versus selective serotonin reuptake inhibitor antidepressants.
Perry PJ
J Affect Disord; 1996 Jun; 39(1):1-6. PubMed ID: 8835647
[TBL] [Abstract][Full Text] [Related]
12. Serum levels and cardiovascular effects of tricyclic antidepressants and selective serotonin reuptake inhibitors in depressed patients.
Rodriguez de la Torre B; Dreher J; Malevany I; Bagli M; Kolbinger M; Omran H; Lüderitz B; Rao ML
Ther Drug Monit; 2001 Aug; 23(4):435-40. PubMed ID: 11477329
[TBL] [Abstract][Full Text] [Related]
13. Selective serotonin reuptake inhibitors versus tricyclic antidepressants in young patients: a meta-analysis of efficacy and acceptability.
Qin B; Zhang Y; Zhou X; Cheng P; Liu Y; Chen J; Fu Y; Luo Q; Xie P
Clin Ther; 2014 Jul; 36(7):1087-1095.e4. PubMed ID: 24998011
[TBL] [Abstract][Full Text] [Related]
14. WITHDRAWN: Treatment discontinuation with selective serotonin reuptake inhibitors (SSRIs) versus tricyclic antidepressants (TCAs).
Barbui C; Hotopf M; Freemantle N; Boynton J; Churchill R; Eccles MP; Geddes JR; Hardy R; Lewis G; Mason JM
Cochrane Database Syst Rev; 2007 Jul; (3):CD002791. PubMed ID: 17636706
[TBL] [Abstract][Full Text] [Related]
15. Selective serotonin reuptake inhibitors and tricyclic antidepressants in combination. Interactions and therapeutic uses.
Taylor D
Br J Psychiatry; 1995 Nov; 167(5):575-80. PubMed ID: 8564311
[TBL] [Abstract][Full Text] [Related]
16. Selective serotonin reuptake inhibitors versus tricyclic antidepressants: a meta-analysis of efficacy and tolerability.
Anderson IM
J Affect Disord; 2000 Apr; 58(1):19-36. PubMed ID: 10760555
[TBL] [Abstract][Full Text] [Related]
17. Fluvoxamine and tricyclic antidepressants (TCAs): how do the TCAs compare as "new" drugs with established fluvoxamine?
Ashford JJ
Int Clin Psychopharmacol; 1995 Jan; 9 Suppl 4():27-31. PubMed ID: 7622820
[TBL] [Abstract][Full Text] [Related]
18. Induction of mania with selective serotonin re-uptake inhibitors and tricyclic antidepressants.
Peet M
Br J Psychiatry; 1994 Apr; 164(4):549-50. PubMed ID: 8038948
[TBL] [Abstract][Full Text] [Related]
19. Cardiovascular effects of antidepressant drugs: updated.
Glassman AH
J Clin Psychiatry; 1998; 59 Suppl 15():13-8. PubMed ID: 9786306
[TBL] [Abstract][Full Text] [Related]
20. Serotonin transporter occupancy with TCAs and SSRIs: a PET study in patients with major depressive disorder.
Lundberg J; Tiger M; Landén M; Halldin C; Farde L
Int J Neuropsychopharmacol; 2012 Sep; 15(8):1167-72. PubMed ID: 22243688
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
